Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

China flag China · Delayed Price · Currency is CNY
7.15
-0.19 (-2.59%)
Mar 19, 2026, 3:00 PM CST
Market Cap6.72B -34.4%
Revenue (ttm)1.59B -48.8%
Net Income-332.62M
EPS-0.35
Shares Out939.26M
PE Ration/a
Forward PEn/a
Dividend0.15 (2.04%)
Ex-Dividend Daten/a
Volume16,212,629
Average Volume12,129,227
Open7.29
Previous Close7.34
Day's Range7.09 - 7.36
52-Week Range7.11 - 13.48
Beta0.23
RSI24.90
Earnings DateApr 23, 2026

About SHA:603567

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China. [Read more]

Sector Healthcare
Founded 1996
Employees 2,349
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603567
Full Company Profile

Financial Performance

In 2024, SHA:603567's revenue was 2.70 billion, a decrease of -13.84% compared to the previous year's 3.14 billion. Earnings were 438.22 million, a decrease of -7.30%.

Financial Statements